Beta-Amyloid (3-42)

Overview

Beta-Amyloid (3-42) is a critical peptide in Alzheimer’s disease research, representing the non-pyroglutamate form of beta-Amyloid (3-42). This peptide is the N-terminally truncated version of beta-Amyloid (1-42), which plays a significant role in the formation of senile plaques. Understanding its structure and function is crucial for studying neurodegenerative conditions and developing therapeutic strategies.

Key Features

• Non-pyroglutamate form of beta-Amyloid (3-42)
• N-terminally truncated version, key for plaque formation research
• Higher aggregation propensity compared to other forms
• Essential for neurological studies, particularly Alzheimer’s
• Available for purchase in precise quantities

Specifications

FAQ

What is Beta-Amyloid (3-42) used for?

Beta-Amyloid (3-42) is used in research related to Alzheimer’s disease, particularly in studies focusing on the aggregation of amyloid plaques.

How is this peptide delivered?

The peptide is provided in a vial, ensuring that you receive a controlled amount for your experiments. Each vial contains a precise measurement, allowing for accurate dosing in your assays.

Can I use Beta-Amyloid (3-42) in vivo studies?

While Beta-Amyloid (3-42) is primarily used for in vitro studies, its applications may extend to in vivo investigations based on specific research needs and protocols.

For those engaged in advanced research, our Beta-Amyloid (3-42) peptide is just one of many essential peptides we offer. Explore our full range of peptides for various applications, including our PKG substrate and Autocamtide-2. Enhance your research with our high-quality products tailored for precision and effectiveness.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.